Envestnet Asset Management
NVCR icon

Envestnet Asset Management’s NovoCure NVCR Stock Holding History

Envestnet Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,159
Closed -$273K – 4438
2024
Q4 		$273K Buy
+9,159
New +$194K ﹤0.01% 3939
2023
Q4 		– Sell
-12,515
Closed -$202K – 4127
2023
Q3 		$202K Buy
12,515
+1,834
+17% +$52.9K ﹤0.01% 3740
2023
Q2 		$443K Sell
10,681
-69,497
-87% -$4.32M ﹤0.01% 3280
2023
Q1 		$620K Buy
80,178
+56,090
+233% +$4.48M ﹤0.01% 3006
2022
Q4 		$1.77M Buy
24,088
+2,755
+13% +$207K ﹤0.01% 2247
2022
Q3 		$1.62M Sell
21,333
-279
-1% -$21.8K ﹤0.01% 2209
2022
Q2 		$1.5M Sell
21,612
-3,518
-14% -$265K ﹤0.01% 2296
2022
Q1 		$2.08M Sell
25,130
-1,745
-6% -$129K ﹤0.01% 2172
2021
Q4 		$2.02M Buy
26,875
+824
+3% +$82.7K ﹤0.01% 2173
2021
Q3 		$3.03M Buy
26,051
+7,161
+38% +$1.08M ﹤0.01% 1831
2021
Q2 		$4.19M Buy
18,890
+2,840
+18% +$552K ﹤0.01% 1627
2021
Q1 		$2.12M Sell
16,050
-295
-2% -$46.7K ﹤0.01% 1901
2020
Q4 		$2.83M Buy
16,345
+390
+2% +$53.4K ﹤0.01% 1556
2020
Q3 		$1.78M Sell
15,955
-1,170
-7% -$93.6K ﹤0.01% 1687
2020
Q2 		$1.02M Buy
17,125
+1,530
+10% +$101K ﹤0.01% 1961
2020
Q1 		$1.05M Buy
15,595
+2,872
+23% +$227K ﹤0.01% 1787
2019
Q4 		$1.07M Buy
12,723
+1,380
+12% +$111K ﹤0.01% 1982
2019
Q3 		$848K Sell
11,343
-1,019
-8% -$81.5K ﹤0.01% 2054
2019
Q2 		$782K Buy
12,362
+697
+6% +$35.3K ﹤0.01% 2109
2019
Q1 		$562K Sell
11,665
-347
-3% -$16.7K ﹤0.01% 2277
2018
Q4 		$402K Buy
+12,012
New +$439K ﹤0.01% 2275
2018
Q3 		– Sell
-4,324
Closed -$135K – 2149
2018
Q2 		$135K Buy
+4,324
New +$120K ﹤0.01% 1875

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Envestnet Asset Management's NVCR Position: Q1 2025 in Review

Envestnet Asset Management sold out of NovoCure (NVCR) in Q1 2025, closing a stake of 9,159 shares — an estimated $273K sold.

Envestnet Asset Management first reported a position in NVCR in Q2 2018 and held it in 22 quarters. The position peaked at $4.19M in Q2 2021. 227 funds tracked by Wall St. Rank hold NVCR as of Q1 2025.

  • Envestnet Asset Management reported no remaining NovoCure position as of Q1 2025 after selling out during the quarter.
  • Envestnet Asset Management sold 9,159 NovoCure shares in Q1 2025, an estimated $273K.
  • Envestnet Asset Management first reported a position in NovoCure in Q2 2018 and held it in 22 quarters.
  • Envestnet Asset Management's NovoCure position peaked at $4.19M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held NovoCure as of Q1 2025.

Based on Envestnet Asset Management's 13F filing for Q1 2025, filed 29 Apr 2025.